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A Diverse Family of GPCRs Expressed in Specific
Subsets of Nociceptive Sensory Neurons
cord (reviewed in Snider and McMahon, 1998). In addi-
tion, C-fibers innervate a variety of peripheral targets
including the skin, gut, vasculature, and muscle. Within
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2 Division of Biology 147-75 these targets, such small-diameter sensory fibers show
several categories of morphologically distinct nerve3 Howard Hughes Medical Institute
California Institute of Technology endings (Fundin et al., 1997; Rice et al., 1997). The mo-
lecular bases of these various aspects of phenotypicPasadena, California 91125
diversity among somatosensory neurons are largely un-
known.
In recent years, our understanding of nociception and
its modulation has been advanced by the identificationSummary
and functional analysis of signaling molecules ex-
pressed in nociceptive sensory neurons (Akopian et al.,In vertebrates, peripheral chemosensory neurons ex-
press large families of G protein-coupled receptors 1996a). These molecules include the vanilloid receptor
VR1, purinergic receptors such as P2X3, and the TTX-(GPCRs), reflecting the diversity and specificity of
stimuli they detect. However, somatosensory neurons, insensitive sodium channel (reviewed in Caterina and
Julius, 1999). Another family of signaling molecules,which respond to chemical, thermal, or mechanical
stimuli, are more broadly tuned. Here we describe a which play a prominent role in various sensory systems,
are G protein-coupled receptors (GPCRs). Severalfamily of approximately 50 GPCRs related to Mas1,
called mrgs, a subset of which is expressed in specific GPCRs are expressed in nociceptive sensory neurons.
These include the NPY receptors, the Protease-Acti-subpopulations of sensory neurons that detect painful
stimuli. The expression patterns of mrgs thus reveal vated receptors (PARs), the bradykinin receptor (re-
viewed in Hunt and Mantyh, 2001), opiate receptorsan unexpected degree of molecular diversity among
nociceptive neurons. Some of these receptors can be (Dado et al., 1993), and prostaglandin receptors (Don-
aldson et al., 2001). More recently, a GPCR expressedspecifically activated in heterologous cells by RFamide
neuropeptides such as NPFF and NPAF, which are in nociceptors, termed R35, has been identified, al-
though its function is unknown (Friedel et al., 2001).analgesic in vivo. Thus, mrgs may regulate nociceptor
function and/or development, including the sensation Here we report the identification of a large GPCR sub-
family comprising almost 50 members that are relatedor modulation of pain.
to MAS1 (Young et al., 1986), called Mas-related genes
(mrgs). A subset of these genes, including mrgAs andIntroduction
mrgD, is specifically expressed in Griffonia simplicifolia
lectin IB4 sensory neurons, a subpopulation that in-Dorsal root (spinal) ganglia contain diverse subpopula-
tions of primary sensory neurons (Scott, 1992). These cludes cutaneous nociceptors and which has been im-
plicated in “neuropathic” (nerve injury-induced) paininclude muscle afferent sensory neurons that project to
motoneurons in the ventral spinal cord and cutaneous (Malmberg et al., 1997). The expression of mrgAs and
mrgD thus reveals an unexpected degree of molecularafferent sensory neurons that project to the dorsal spinal
cord. Within the subclass of cutaneous afferent sensory diversity among nociceptive sensory neurons. Their ex-
pression in these neurons further suggests that theyneurons, there is further diversification into low-thresh-
old mechanoceptors and high-threshold nociceptors. could be involved in pain sensation or its modulation.
In heterologous cells, mrgA1 and A4 can be activatedThis latter category includes neurons that respond to
a variety of noxious thermal, mechanical, or chemical by the RFamide neuropeptides NPFF and NPAF, respec-
tively, which produce long-lasting analgesic effectsstimuli that cause acute pain (Willis and Coggeshall,
1991). In addition, such nociceptive neurons mediate when injected intraspinally (reviewed in Panula et al.,
1999). These data, and the specificity of expression ofchronic pain associated with inflammatory responses
or nerve injury (so-called “neuropathic” pain). mrgAs and mrgD, suggest that ligands for these recep-
tors may include neuropeptides that modulate pain sen-Nociceptive sensory neurons exhibit further diversifi-
cation (reviewed in Caterina and Julius, 1999; Hunt and sitivity.
Mantyh, 2001). For example, these neurons can be sub-
divided into so-called A and C-fibers based on their Results
spike-firing thresholds and the presence or absence
of myelination, respectively. C-fibers, in turn, can be Identification of mrgA, mrgB, and mrgC Subfamilies
subclassified into those that express proinflammatory Previous studies have shown that in mouse embryos
neuropeptides, such as Substance P, and a “nonpeptid- lacking the bHLH transcription factor Neurogenin1
ergic” subclass that does not (Molliver et al., 1997; Ben- (Ngn1) (Ma et al., 1996), most trkA neurons, which in-
nett et al., 1998; Stucky and Lewin, 1999); these sub- clude the nociceptive subclass, fail to be generated (Ma
classes project to distinct laminae in the dorsal spinal et al., 1999). We exploited this mutant phenotype to
isolate genes specifically expressed in such neurons by
subtracting cDNAs from neonatal wild-type and Ngn1/4 Correspondence: wuwei@caltech.edu
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DRG (see Experimental Procedures). Genes expressed gesting that the receptors have a shared function. The
in the former but not the latter cDNA population should most divergent regions of mrgA-family receptors appear
be specific to trkA neurons. Consistent with this idea, localized to the extracellular loops (Figures 1A, E1, E2,
the screen yielded several signaling molecules known etc.), suggesting that these receptors recognize dif-
to be involved in nociceptor functions, including the ferent ligands, or the same ligand but with different af-
capsaicin receptor VR1 (Caterina et al., 1997), CGRP, and finities. Interestingly, we identified 12 single nucleotide
SNS, the sensory neuron-specific, tetrodotoxin-insensitive polymorphisms in the mrgA1 coding sequence be-
sodium channel  subunit (Akopian et al., 1996b). tween murine strains C57BL/6J and 129/SvJ. These 12
The screen also identified at least five previously un- changes resulted in six amino acid substitutions, all of
known genes. Among these, one encoded a receptor which were either conservative, or which substituted
protein with seven transmembrane segments, a charac- residues expressed at the same position by other family
teristic of GPCRs. This GPCR shows highest homology members.
(35% identity) to MAS1 (Young et al., 1986). It also shares A large mouse genomic contig was built by analyzing
significant homology (30%–35% identity) with two other overlapping BAC clones containing mrgA sequences
mammalian GPCRs, called Mas-related gene 1 (mrg1) (Figure 1C). There are seven mrgA genes, including three
(Monnot et al., 1991) and rat thoracic aorta (RTA) (Ross pseudogenes, residing in this contig. Such clustering is
et al., 1990). Based on its homology with the Mas gene a common feature of GPCR-encoding gene families (Xie
family, we named this receptor mrgA1 (Mas-related et al., 2000). Strikingly, all of the human mrg genes (with
gene A1). Further screening of murine DRG cDNA and the exception of Mas1 and mrg1) are located on chromo-
BAC libraries led to the identification of seven additional some 11, which also contains nearly 50% of all human
closely related (70%–80% identity) full-length genes olfactory receptors genes (Glusman et al., 2001). All of
(mrgsA2–8) (Figure 1A). Since mrgA genes are highly the mrgA genes in the murine BAC contig (Figure 1C)
homologous to each other (see Supplementary Table encode intact ORFs with N-terminal methionines, like
S1A, Supplemental Data, below) and have certain char- many other GPCR-encoding genes. Using the Celera
acteristic conserved residues, they define a subfamily mouse genome database, sequences flanking each
of the MAS family of GPCRs. mrgA coding region were obtained and analyzed. This
Computer searches (see Experimental Procedures) analysis revealed that at least nine mrgA genes have L1
using mrgA1 as the query sequence revealed 14 addi- retrotransposon sequences located 650 bp down-
tional members of the murine mrgA subfamily (Figure stream of their coding sequences (Figure 1B, L1).
1B). In addition to this subfamily, two closely related
mrg subfamilies, called mrgB and mrgC, were also dis- mrgAs and mrgD Are Expressed in Subsets
covered by such database searches (Figure 1B). The of Primary Sensory Neurons
mrgB subfamily contains 13 genes, whereas mrgC has To determine whether mrgAs are expressed in DRG
14 members. The percent sequence identity within each neurons, in situ hybridization using dioxygenin-labeled
of these subfamilies is 50% (see Table S1A, Supple- riboprobes was performed for the eight mrgA cDNA
mental Data, below). Strikingly, all 14 mrgC members
clones initially isolated from the DRG cDNA and BAC
appear to be pseudogenes (Figure 1B, “”), as they
libraries. This analysis revealed that all eight mrgAs
contain multiple premature stop codons, frameshift mu-
(mrgA1–8) are expressed in subsets of sensory neurons,
tations, or both. Thus, the mrgA, mrgB, and mrgC sub-
in wild-type neonatal DRG (Figures 2B–2I). Importantly,families comprise almost 50 sequences, of which 27
the expression of all eight mrgAs was virtually absentencode intact ORFs.
in DRGs of Ngn1/ animals (Figure 2J and data notSearches of the Celera (Venter et al., 2001) and public
shown), consistent with the design of the subtractive(I.H.G.S., 2001) genomic sequence databases, using
hybridization screen. Among the eight mrgA clones ex-both BLAST (Altschul et al., 1990) and Hidden Markov
amined, mrgA1 has the widest expression within sen-Models (HMMs; Eddy, 1998), revealed four closely re-
sory neurons in neonatal DRGs (13.5%). Other mrgAslated (50% identity) full-length human genes and at
are only expressed in several cells per DRG sectionleast nine human pseudogenes (Figure 1B, Hs.mrgX1,
(ranging from 0.2%–1.5% of DRG neurons). This differ-etc.). Although the human genes appear to be more
ential abundance may explain why only mrgA1 was iso-similar to the murine mrgA subfamily than the mrgB
lated in the original screen. No obvious differences insubfamily in the phylogenetic tree (Figure 1B, hmrgX1-
the expression patterns of mrgA1–8 were noticed in4), in the absence of clear orthologous pairs we currently
DRGs from different axial levels.refer to them as Hs.mrgX genes. In addition to the mrgA,
The expression of mrgAs in sensory neurons appearsB, and C subfamilies, a number of additional Mas1-
highly specific, in that in situ hybridization signals haverelated orphan GPCRs were identified by this search,
not been detected in any other tissue of the body exceptincluding those we refer to as mrgs D–G (Figure 1B).
trigeminal ganglia (Figure 2K, arrowhead, and data notMost of these sequences have clear human orthologs
shown). Like the mrgA genes, mrgD was also specifically(Figure 1B and Table S1B, Supplemental Data, below).
expressed in a subset of DRG sensory neurons, andAltogether, we identified almost 31 murine and 8 human
was not detectable in any other tissue except trigeminalintact coding sequences belonging to this family of
ganglia in neonatal animals (Figure 2L, arrowhead; seeGPCRs.
below). In contrast, expression of other mrgs, includingMrg receptors have short (3–21 amino acid) N termini,
mrgB1-5, Mas1, mrgE, mrgF/RTA, mrgG, and GPR90,with no apparent signal peptide, which are predicted to
was not detectable in DRGs (data not shown). Prelimi-be located extracellularly. The transmembrane domains
and intracellular domains are highly conserved, sug- nary Northern blot analysis using Hs.mrgX1 and X2 as
A GPCR Family Expressed in DRG Nociceptive Neurons
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Figure 1. mrgA Genes Are Members of a Large Family of G Protein-Coupled Receptors
(A) Alignment of amino acid sequences of mrgA1-A8. Residues shaded in black are identical in 50% of the predicted proteins; similar
residues are highlighted in gray. The predicted transmembrane (TM1-TM7), extracellular (E1-E4), and cytoplasmic (C1-C4) domains are
indicated.
(B) Phylogenetic analysis of murine (Mm) and human (Hs) mrg family members. The protein sequences were aligned using CLUSTALW
(Thompson et al., 1994). Mouse formyl peptide receptor 1 (Mm.FMLP) was used as the outgroup. The dendrogram was generated with the
PHYLUP software package using the Neighbor-Joining method and 1,000 bootstrap trials. The horizontal length of the branches is proportional
to the number of amino acid changes. Vertical distances are arbitrary. Murine mrg genes with retrotransposon sequences 650 nt 3 of their
stop codon are highlighted (L1). , predicted pseudogenes.
(C) Chromosomal organization of one mouse mrg gene cluster deduced from analysis of overlapping BAC clones. The cluster contains four
intact ORFs and three pseudogenes.
probes failed to reveal detectable expression in a panel tion studies using probes labeled with digoxigenin and
fluorescein indicated that in neonates, many neuronsof 12 different human tissues; however these did not
include DRG (not shown). expressing mrgA3 or mrgA4 coexpress mrgA1 (Figures
3A–3F, arrowheads). In addition to strongly labeled
mrgA4 cells (Figure 3E, arrowhead), the fluorescentDifferent mrgAs Are Expressed in Largely
Nonoverlapping Subsets of Sensory Neurons in situ hybridization signals for mrgA4 using tyramide
amplification included dots within nuclei that were cir-The in situ hybridization data obtained using individual
mrgA probes raised the question of whether these re- cumscribed by the cytoplasmic expression of mrgA1
mRNA, as detected by fast red (Figure 3F, arrow). Suchceptors are expressed by distinct or overlapping sub-
sets of sensory neurons. Double-label in situ hybridiza- dots of mrgA4 expression were not observed using the
Cell
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Figure 2. mrgAs Are Expressed in Subsets of Nociceptive Sensory Neurons
(A–I) In situ hybridization with cRNA probes detecting trkA (A) and mrgA1-A8 (B–I).
(J) mrgA1 Expression is eliminated in Ngn1/ mice, as is expression of other mrgA genes (not shown). Remaining DRG neurons are present
in the area delimited by the dotted line (not shown; see Ma et al., 1999).
(K and L) Cross-sections through the trunk region of neonatal mice hybridized with probes for mrgA1 (K) and mrgD (L). Arrowheads indicate
specific expression in the DRG. Expression was not detected in any other tissue, at this or at other axial levels (data not shown).
less sensitive fast red detection method, and were only press mrgA1 in newborn animals. In adults, however,
mrgA1 is expressed by a smaller subset of sensory neu-observed in the nuclei of mrgA1 cells. Similar intra-
nuclear dots have previously been observed in studies rons and only partially overlaps the expression of other
mrgAs (see below).of pheromone receptor gene expression, and have been
suggested to represent sites of transcription (Pantages To address the question of whether mrgsA2-A8 are
expressed in the same or in different neurons, we com-and Dulac, 2000). Other mrgA probes gave insufficiently
strong signals to be used in such double-labeling experi- pared the number of neurons labeled by single probes
to that labeled by a mixture of all seven probes (Buck andments. Nevertheless, the results for mrgA1, 3, and 4
suggested that those neurons that express the rarer Axel, 1991). Approximately 3-fold more neurons (4.5%
versus 1%) were labeled by the mixed mrgsA2-A8 probemrgA genes (mrgA2-8) are a subset of those that ex-
A GPCR Family Expressed in DRG Nociceptive Neurons
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Figure 3. Partially Overlapping Expression of
Different mrgAs in Neonatal Sensory Neurons
(A–C) Double label in situ hybridization with
mrgA1 (A, red) and A3 (B, green).
(D–F) Double labeling with mrgA1 (D) and
mrgA4 (E). In neonates, cells expressing
mrgA3 or A4 are a subset of those expressing
mrgA1 (C and F, arrowheads). However, in
adults, mrgA1 is mostly nonoverlapping with
other mrgAs.
(G–I) Double label in situ with mrgA1 and
mrgD. Expression is mostly nonoverlapping
(I, arrows), although some double-positives
are seen (I, arrowhead). Vertical bars (C, F,
and I) represent a z-series viewed along the
y axis, horizontal bars a z-series viewed along
the x axis, confirming double-labeling of the
same cells.
(J and K) Comparison of in situ experiments
using a single mrgA4 probe (J) versus a mix-
ture of seven mrgA probes (K).
than by an individual probe (mrgA4; Figures 3J and 3K), pressed both genes. 34% (118/344) of mrgA1 cells
coexpressed mrgD, while 26.7% (118/442) of mrgDindicating that these genes are not all coexpressed in
the same population of neurons. However, the percent- cells coexpressed mrgA1. This partial overlap at birth,
however, is transient, and the expression of mrgAs andage of neurons labeled by the mixed probe (4.5%) was
less than the sum of the percentage of neurons labeled mrgD becomes segregated in adulthood (see below). A
similar pattern of transient coexpression followed byby each of the seven individual probes (6.6%). This ob-
servation, and the fact that a higher signal intensity was segregation has been observed for other receptors ex-
pressed in subsets of DRG sensory neurons, such asobserved in individual neurons using the mixed probe
than using a single probe, suggests that there is some trkA and c-ret (Molliver et al., 1997).
overlap in the expression of mrgA2-A8, at least at birth.
We next examined the relationship between neurons Mrgs Are Expressed in a Subset of trkA Neurons
at Birthexpressing mrgA1 and mrgD. In neonatal DRG, there
was a partial overlap between mrgA1 and mrgD cells The lack of expression of mrgAs in DRGs from Ngn1/
mice is consistent with the idea that they are expressed(Figures 3G–3I, arrowheads). Approximately 15% (118/
786) of neurons expressing either mrgA1 or mrgD coex- in trkA sensory neurons, which include nociceptors
Cell
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Figure 4. Expression of mrgs in Neonatal
DRG
1 m confocal microscope optical sections
of P0 DRG hybridized in situ with the indi-
cated mrg probes (red), combined with fluo-
rescent antibody detection of trkA (A–D), sub-
stance P (SubP, I–L), CGRP (M–P), VR1 (Q–T),
or staining with fluorescent lectin IB4 (IB4;
E–H) (green). IB4 labels blood vessels in addi-
tion to neurons in DRG. Arrows in (I) and (M)
indicate a minor subset of mrgA1 neurons
that coexpresses Substance P and CGRP.
(McMahon et al., 1994; Snider and Silos-Santiago, 1996). 4I–4L, arrowheads). Similarly, all mrgD cells, and many
mrgA cells, do not express CGRP (Figures 4M–4P, ar-Furthermore, the distribution of mrgA1cells was similar
to that of trkA cells on adjacent sections (Figures 2A rowheads), another neuropeptide expressed by C-fiber
nociceptors.and 2B). To directly determine whether mrgA genes are
expressed in trkA cells, in situ hybridization was per- Recent studies have provided evidence for the exis-
tence of two neurochemically and functionally distinctformed on neonatal DRG for mrgA1, A3, and A4 in con-
junction with immunolabeling using anti-trkA antibodies. subpopulations of IB4 nociceptors: those that express
the vanilloid receptor VR1 (Caterina et al., 1997), andThese experiments confirmed that mrgAs are indeed
coexpressed in trkA neurons (Figures 4A–4C, arrow- those that do not (Michael and Priestley, 1999; Stucky
and Lewin, 1999). Strikingly, in situ hybridization withheads) at birth. Similar results were obtained for mrgD
(Figure 4D, arrowhead). These data suggest that mrgAs mrgA or D probes combined with anti-VR1 antibody
immunostaining indicated that the mrgA1, A3, A4, andand mrgD are specifically expressed in a population of
sensory neurons that contains nociceptive as well as D-expressing cell populations were mutually exclusive
with VR1 cells (Figures 4Q–4T, arrowheads). In sum-other neuronal subtypes.
To determine whether mrgs are expressed in more mary, these expression data suggest that mrgA and D
genes are expressed in the subclass of nonpeptidergicrestricted subsets of such neurons, additional double-
labeling experiments were carried out. Combined fluo- sensory neurons that are IB4 and VR1 (Figure 5CC).
rescent labeling for isolectin B4 (IB4) together with in
situ hybridization with mrgA1, A3, A4, and mrgD probes Expression of mrgAs and mrgD in Adult DRG
Identifies At Least Two Distinct Subsetssuggested that these receptors are expressed by IB4
neurons (Figures 4E–4H, arrowheads), an assignment of IB4, VR1 Sensory Neurons
The finding that mrgAs and mrgD are expressed in trkA,confirmed by analysis of adult DRG (see below). This
result implies that mrgs are expressed by nonpeptider- IB4 sensory neurons at birth is consistent with the
fact that the latter two markers are coexpressed bygic nociceptive neurons that project to lamina IIi (Snider
and McMahon, 1998). Consistent with this assignment, nonpeptidergic sensory neurons in neonates (Molliver
et al., 1997). During the second postnatal week, how-the majority (90%) of mrgA1, and all mrgA3, mrgA4,
and mrgD cells, lack substance P expression (Figures ever, the IB4 neurons downregulate expression of trkA,
A GPCR Family Expressed in DRG Nociceptive Neurons
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Figure 5. Expression of mrgs in adult DRG
Shown are 1 m confocal microscope optical
sections of adult DRG processed for double-
label in situ hybridization with the indicated
markers. In all panels, mrgs are in red, the
countermarkers in green. All countermarkers
are cRNA in situ hybridization probes except
fluorescent IB4 lectin and anti-trkA antibody.
Arrowheads indicate single-positive cells,
arrows double-positive cells. Expression of
mrgAs is restricted to neurons that express
lower levels of c-ret mRNA than do mrgD-
expressing neurons (E–G, arrows). Insets
show the boxed cells at higher magnification
with the red and green channels separated.
(CC) Schematic illustrating restriction of
mrgA (and mrgD) expression to nonpeptider-
gic, IB4, VR1– sensory neurons (orange with
purple fill) that project to lamina IIi, marked
by expression of PKC	 (magenta stippling).
(DD) Venn diagram illustrating the different
subsets of IB4, VR1 DRG neurons defined
by expression of mrgAs and mrgD. The draw-
ing is a conservative estimate of the number
of subsets; their sizes are not proportional.
For simplicity, all mrgAs except A1 are con-
densed into a single group, although there is
likely relatively little overlap between these
mrgAs (see Figures 3J and 3K).
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626
and become dependent on the neurotrophic factor tion that accompanies in situ hybridization, we per-
GDNF, whose receptor, c-ret, they continue to express formed pairwise comparisons of the average diameter
(Molliver et al., 1997). To determine whether expression of mrgA1, A3, A4, and mrgD neurons with that of
of mrgs is maintained in the trkA subpopulation, or VR1 neurons (whose cell diameters are characteristic
rather the c-ret/IB4 population, we performed a series of nociceptors (Tominaga et al., 1998)), on the same
of double-labeling experiments on DRG from adult (4 double-labeled sections (Figures 5Y–5BB). This analysis
week postnatal) mice. indicated that the average diameter of mrgA1 (19.7 

Expression of both mrgAs and mrgD was maintained 2.94 m), mrgA3 (20.7 
 1.7 m), mrgA4 (19.9 
 2.47
in IB4 neurons in adulthood (Figures 5I–5L arrows). All m), or mrgD (21.9 
 1.98 m) cells is slightly but
mrgD neurons coexpressed IB4, as did the majority significantly less than that of VR1 neurons (24.3 
 4.94
(90%) of mrgA cells. As expected from these data, m; p.0064 or less for all pairwise comparisons be-
the mrgs no longer colocalized with trkA in adult DRGs tween mrg and VR1 neurons). These data indicate
(Figures 5A–5D, arrowheads). Consistent with their ex- that mrg cells fall within the size range characteristic
pression in IB4 cells, 100% of mrgD cells strongly of small-diameter nociceptive sensory neurons.
coexpressed c-ret (Figure 5H, arrow). Similarly, the ma-
jority (93%) of mrgA cells were c-ret (Figures 5E–5G, mrgA1 and A4 Can Function as Receptors
arrows). However, the level of c-ret expression was con- for Neuropeptides
sistently lower in the mrgA cells than in the mrgD The structure of the proteins encoded by mrg genes
cells, and was often restricted to the perimeter of the suggests that they function as receptors. As a first step
cell body (Figures 5E–5G, insets; cf. Figure 5H, arrow). toward testing this hypothesis, we sought to determine
These data suggested that mrgAs and mrgD might be whether these GPCRs could be activated by any known
expressed by distinct subsets of IB4 neurons, which ligands. To this end, we cloned selected mrgA genes,
differ quantitatively in their level of c-ret expression. including mrgA1 and mrgA4, into a eukaryotic expres-
Double-labeling experiments with mrgA versus mrgD sion vector and transfected them into human embryonic
probes in adult DRGs confirmed that these receptors kidney (HEK) 293 cells. By fusing GFP to the C termini
are expressed in nonoverlapping populations of neurons of the mrgA coding sequences, we were able to visualize
(not shown). MrgD neurons coexpressed the purinergic the intracellular distribution of the receptors and confirm
receptor P2X3 (Chen and McConnell, 1995) (Figure 5P, their membrane integration in the transfected cells (see
arrow), consistent with the fact that this receptor is Supplemental Figure S1D, Supplemental Data, below).
known to be mostly restricted to the IB4 population To increase the sensitivity of the assay, in some experi-
(Bradbury et al., 1998). In contrast, most mrgA cells ments the mrgA-GFP fusion proteins were expressed in
did not coexpress P2X3 (Figures 5M–5O, arrowheads). HEK 293 cells modified to express G15, which couplesAs was the case in neonates, mrgA and mrgD cells GPCRs to a signal transduction pathway leading to the
did not coexpress the neuropeptide Substance P (Fig- release of intracellular free Ca2 (Offermanns and Simon,
ures 5U–5X), and mrgD cells were also negative for 1995). This calcium release can be monitored ratiometri-
CGRP (Figure 5T, arrowhead). In contrast, approxi-
cally using Fura-2 as a fluorescent indicator dye (Tsien
mately 50% of mrgA cells were CGRP (Figures 5R
et al., 1985) (see Figures S1A–C, Supplemental Data).
and 5S, arrows), consistent with the fact that a subset
This heterologous expression system has been pre-
of IB4 cells are known to express this neuropeptide
viously used to identify ligands for taste receptors(Bradbury et al., 1998). The vanilloid receptor VR1 con-
(Chandrashekar et al., 2000).tinued to be excluded from both the mrgA and mrgD
Because mrgAs exhibit the highest sequence similar-subpopulations (Figures 5Y–5BB), as was the case at
ity to peptide hormone receptors, we screened approxi-birth. These data confirm that expression of mrgs is
mately 45 candidate peptides for their ability to activaterestricted in adults to a subset of IB4 sensory neurons
mrgA1 using this intracellular Ca2-release assay. At athat are VR1, as suggested by the data from neonatal
concentration of 1 M, numerous neuropeptides pro-animals (Figure 5CC). Moreover, our data reveal two
duced some level of activation of mrgA1-expressingdistinct subsets of neurons within the IB4, VR1 popu-
cells (Figure 6A). These included ACTH, CGRP-I andlation: mrgA neurons are c-retlow and mostly P2X3,
-II, NPY, and somatostatin (SST). Nevertheless, manywhile mrgD cells are c-rethigh and P2X3 (Figure 5DD).
other peptide hormones did not activate mrgA1, includ-Furthermore, while in neonates there is overlap between
ing angiotensins I–III and neurokinins A and B, -MSH,mrgA1 and other mrgAs, in adults the mrgAs are largely
and 	2-MSH (Figure 6A and data not shown). mrgA1-nonoverlapping (not shown). Therefore, the mrgA sub-
expressing cells were only very weakly activated by eco-set is likely further subdivided into different subpopula-
sanoid ligands such as prostaglandin-E1 and arachi-tions expressing different mrgsAs (Figure 5DD).
donic acid (data not shown). Nontransfected HEK-G15The expression of mrgAs and mrgD in IB4 cells sug-
cells were strongly activated by PACAP, VIP, and ATP,gests that these receptors are present in a population
and weakly activated by secretin, endothelin, and helo-of sensory neurons that terminate in lamina IIi ((Bennett
dermin. No responses to bradykinin were detected inet al., 1998); Figure 5CC), which includes nociceptors
HEK-G15 cells, although the parental HEK 293 cells(Molliver et al., 1997). Another classical criterion for sen-
showed responses to this peptide as previously re-sory neuron subtype is cell body diameter: nociceptive
ported (Anderson et al., 1995).sensory neurons typically have the smallest cell somata
The most efficient responses in mrgA1-expressingof all neurons in the DRG (Scott, 1992). Although an
HEK cells were elicited by RFamide peptides, includingaccurate measurement of absolute cell somata diame-
ters for mrg neurons is precluded by the tissue distor- FLRF and the molluscan cardioactive neuropeptide
A GPCR Family Expressed in DRG Nociceptive Neurons
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FMRFamide (Price and Greenberg, 1977) (Phe-Met-Arg- MrgAs Exhibit Characteristic Activation
and Desensitization KineticsPhe-amide) (Figures 6A and S1C, Supplemental Data).
to Neuropeptide LigandsWe therefore tested two mammalian RFamide peptides,
To further characterize the response of mrgA receptorsNPAF and NPFF, which are cleaved from a common
to their preferred neuropeptide ligands, we examinedpropeptide precursor (Vilim et al., 1999). The response
their activation and desensitization kinetics. Addition ofof mrgA1-expressing cells to NPFF at 1 M was similar
1M FLRF and NPAF to mrgA1- and mrgA4-transfectedto that seen with FMRFamide, while that to NPAF was
HEK-G15 cells, respectively, elicited a rapid rise insignificantly lower (Figure 6A). mrgA1 was also weakly
[Ca2]i, with peak responses achieved within 10–20 sactivated by two other RFamide ligands, 	1-MSH and
following agonist stimulation (Figures 6G and 6H). TheschistoFLRF (data not shown).
responses were sustained for 500 s, after which theyIn order to examine further the specificity of activation
slowly returned to baseline (not shown). To determineof mrgA1 and A4, we retested the top candidate ligands
whether the activation kinetics or ligand selectivity wereemerging from the initial screen on these same recep-
affected by the GFP fusion at the C terminus of thetors expressed in HEK 293 cells lacking G15. MrgA1
receptors, the experiments were repeated using V5 epi-and A4 expressed in this system retained responses to
tope-tagged or untagged forms of mrgA1 and A4 in bothRFamide peptides at a concentration of 1 M (Figures
HEK-G15 and parental HEK 293 cells. No differences in6B and 6C). This suggests that mrgAs may act in HEK
relative selectivity or activation kinetics were found in293 cells via Gq or Gi/o. The response of mrgA1-express-
response to FLRF, NPFF, NPAF, and ACTH in theseing HEK 293 cells to NPFF was lower than that to FLRF
experiments (not shown).(Figure 6B), and there was no response to NPAF. Con-
Finally, to determine whether mrgAs undergo desensi-versely, mrgA4-expressing cells responded to NPAF,
tization in response to their preferred ligands, HEK 293but not to NPFF or FLRF (Figure 6C). In both cases, the
cells expressing untagged forms of mrgA1 or mrgA4response to NPY seen in G15-expressing cells (Figure
were challenged with multiple pulses of 1 M FLRF or6A) was lost completely, while those to CGRP-II and
NPAF, respectively. The successive application of theseACTH were considerably diminished.
ligands in both cases led to progressively reduced peakIn order to determine the lowest concentrations of
responses, indicative of densensitization (Figures 6I andRFamide ligands capable of activating mrgA1 and A4,
6J; see insets) (Kobilka, 1992). Following each succes-we performed dose reponse experiments in HEK-G15
sive ligand application and washout, responses returnedcells, which afforded greater sensitivity (Figures 6D and
to baseline in 200 s, slightly faster than observed with6E). These experiments indicated that mrgA1 could be
HEK-G15 cells (see above). Recovery from desensitiza-activated by FLRF at nanomolar concentrations (Figure
tion was observed after ligand washout and incubation6D, squares; EC50 20 nM), and by NPFF at about an
for 15–20 min (Figures 6I and 6J; break in abscissa).order of magnitude higher concentration (Figure 6D, cir-
Continuous exposure to the ligands for 20 s resultedcles; EC50 200 nM), whereas NPAF was much less
in adaptation, seen as a fast increase in [Ca2]i followedeffective. In contrast, mrgA4 was well activated by NPAF
by a slower deactivation (not shown). Similar results(Figure 6E, triangles; EC50 60 nM), and much more
were obtained using GFP- or V5-epitope-tagged formsweakly activated by FLRF and NPFF. Neither receptor
of the receptors (not shown). Taken together, these datawas activated well by RFRP-1, -2, or -3, a series of
indicate that mrgA1 and A4 exhibit activation and desen-RFamide ligands produced by a different precursor (Hi-
sitization kinetics in response to their preferred neuro-numa et al., 2000). These data therefore confirmed that
peptide ligands, a characteristic feature of GPCRs (Ko-mrgA1 and mrgA4 display different selectivities toward
bilka, 1992).
different RFamide ligands in this system. By contrast,
these receptors responded similarly to ACTH (EC50 60 Discussion
and 200 nM for mrgA1 and A4, respectively; data not
shown).
Vertebrate peripheral chemosensory neurons express
Finally, given the sequence similarity between mrgA large families of GPCRs (Buck and Axel, 1991; Dulac
receptors and MAS1, we tested the responsiveness of and Axel, 1995; Troemel et al., 1995; Matsunami and
cells expressing exogenous Mas1 to NPFF, NPAF, and Buck, 1997; Adler et al., 2000; Matsunami et al., 2000),
FLRF. MAS1 showed a profile distinct from both mrgA1 reflecting the diversity of ligands that these sensory
and mrgA4 (Figure 6F): like mrgA1, it was activated by systems have evolved to detect. In contrast, primary
NPFF at a similar concentration of the peptide (EC50 somatosensory neurons are thought not to specifically
400 nM), but unlike mrgA1, it was poorly activated by discriminate amongst different chemical ligands, but
FLRF. In contrast to mrgA4, MAS1 did not respond well rather respond to polymodal stimuli (thermal, chemical,
to NPAF. We did not detect responses in MAS1-express- mechanical) by virtue of broadly tuned receptors such
ing cells exposed to Angiotensins I and II, ligands which as VR1 (Tominaga et al., 1998). Here we describe a gene
have been previously reported to activate this receptor family consisting of close to 50 MAS1-related GPCRs,
(Jackson et al., 1988). Nor did MAS1 respond to ACTH. the expression of which reveals an unanticipated degree
Thus, MAS1, mrgA1, and mrgA4 expressed in this heter- of molecular diversity among DRG sensory neurons. The
ologous system are all activated by RFamide family li- specific expression of mrgAs and mrgD in a subset
gands, but with differing ligand sensitivities and selectiv- of IB4 sensory neurons further suggests that these
ities (Table 1). Importantly, nontransfected HEK-G15 receptors may be involved in the sensation or modula-
cells were not activated by any of these RF-amide li- tion of pain, and could therefore provide targets for
antinociceptive drugs.gands (Figures 6D–6F, open symbols).
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Figure 6. Activation of mrgA Receptors Expressed in Heterologous Cells by Neuropeptide Ligands
(A) HEK-G15 cells (Offermanns and Simon, 1995) expressing mrgA1 were tested with the indicated ligands at a concentration of 1 M. The
data indicate the mean percentages of GFP-positive (i.e., transfected) cells showing calcium responses. None of the agonists indicated
showed any responses through endogenous receptors in untransfected cells.
A GPCR Family Expressed in DRG Nociceptive Neurons
629
al., 1998). These neurons primarily send their centralTable 1. Selectivity of Activation of Mas-Related GPCRs
by RFamide Ligands in HEK-G15 Cells projections to lamina IIi (Snider and McMahon, 1998),
which has been implicated in neuropathic pain (Malm-Ligand
berg et al., 1997). These data suggest that mrgAs and
Receptor FLRF NPFF NPAF mrgD are likely expressed in nociceptive sensory neu-
mrgA1   / rons. In support of this assignment, nociceptors tend
mrgA4 / /  to be the smallest-diameter neurons in the DRG (Scott,
MAS1 /  / 1992), and the average cell body diameters of mrgA
and mrgD cells are similar to, or smaller than, that ofRelative efficacy of activation of the indicated receptors by the
indicated ligands is shown. For quantification, see Figure 6. “” VR1 neurons, which are known nociceptors (Tominaga
indicates 10 nM  EC50  100 nM; “” indicates 100 nM  EC50  et al., 1998; Caterina et al., 2000). However, mrgA and/
500 nM; “/” indicates weak response seen at 1 M. For details or mrgD neurons may also include low threshold cuta-
see Figure 6.
neous mechano- or thermoreceptors. These functions
are not mutually exclusive: mrg sensory neurons may
be polymodal.
Structure and Evolution of the mrg Family Strikingly, both mrgAs and mrgD are expressed by
The murine mrg family of GPCRs contains three major VR1 neurons within the IB4 population. VR1 is acti-
subfamilies (mrgA, B, and C), each consisting of 10 vated by both noxious thermal and chemical stimuli
highly duplicated genes. In contrast, we were able to (Tominaga et al., 1998), but in vivo is dispensable for
identify only four intact human mrgX sequences. The the detection of noxious mechanical stimuli (Caterina et
remaining nine human mrg sequences appear to be al., 2000). While VR1 neurons may detect such mechan-
pseudogenes. Why do mice have more mrg genes than ical stimuli via other receptors, it is also possible that
do humans? In the case of odorant receptors, the high mrgA and/or mrgD neurons detect stimuli of different
percentage of pseudogenes in humans (70%; Mom- modalities than are detected by VR1 neurons, including
baerts, 1999) may reflect the decreased reliance of H. noxious mechanical stimuli. Genetic ablation or silenc-
sapiens on olfaction in relation to other sensory modal- ing of mrgA- and mrgD-expressing neurons may permit
ities, such as vision. In the case of the mrgs, it may their assignment to specific sensory modalities, irre-
reflect differences in nociception and/or mechanocep- spective of the function of mrgs themselves.
tion between mice and humans, perhaps related to the
presence or absence of fur and whiskers. However, the Expression of mrgs Defines a Distinct Axis
presence of L1 retrotransposon elements near several of Diversity among IB4 Sensory Neurons
mrg genes raises the possibility that their expansion may The expression of mrgAs and D reveals an unanticipated
have been driven by L1-mediated transduction (Brosius, degree of diversity among IB4, VR1 sensory neurons
1999; Goodier et al., 2000). If so, then the apparently (Figure 5DD). It is currently not clear what aspect of
higher level of ongoing retrotransposon activity in mice cellular or functional diversity this molecular heteroge-
compared to humans (I.H.G.S., 2001) could also account neity underlies. The mrgD subpopulation coexpresses
for the greater size of the murine mrg gene family. How- P2X3, while mrgA neurons mostly do not. MrgD and
ever, the observation that strain-specific polymor- mrgA neurons may therefore have different physiologi-
phisms in these genes (C57BL/6J versus 129/SvJ) are cal properties. The IB4 population is known to contain
either silent, or result in conservative amino acid substi- both unmyelinated (C-fibers) and small, thinly myelin-
tutions, argues against the idea that the diversity of mrg ated (A) neurons (Jackman and Fitzgerald, 2000), but
genes in mice has no functional relevance and simply the relationship of these physiological properties to mrg
reflects expansion of “selfish DNA.” expression remains to be determined.
Even further heterogeneity among IB4, VR1neurons
is implied by the potential expression of up to 17 differ-mrgAs and D Are Expressed in a Specific Subset
of Sensory Neurons that Includes Nociceptors ent mrgA genes. Interestingly, the peripheral nerve end-
ings of IB4 fibers in skin and whisker pads exhibitSome clues to the function of mrgs may be provided by
the specific subpopulation of neurons in which they are significant anatomical diversity, including so-called pen-
icillate endings, bush endings, cluster endings, and freeexpressed. MrgA1-8 and D are all expressed by IB4,
c-ret sensory neurons (Molliver et al., 1997; Bennett et nerve endings (Fundin et al., 1997; Rice et al., 1997).
(B and C) Ligand selectivity of mrgA1 (B) and mrgA4 (C) expressed in HEK cells lacking G15. The cells were exposed to ligands at a
concentration of 1 M as in (A).
(D–F) Dose-response curves for mrgA1 (D), mrgA4 (E), and MAS1 (F) expressed in HEK-G15 cells to selected RFamide neuropeptides. Each
data point represents the mean
SEM of at least three independent determinations; at least 20 GFP cells were analyzed for each determination.
Responses at each ligand concentration were normalized to the maximal response subsequently elicited by a 5 M concentration of the
optimal ligand (FLRF, NPAF, and NPFF in D, E, and F, respectively). Open symbols indicate lack of a response in nontransfected HEK-G15
cells to the peptides identified by the corresponding closed symbols.
(G–J) Activation and desensitization kinetics of mrgA1 and mrgA4 in response to their preferred neuropeptide ligands. (G and H) Single cell
[Ca2]i transients recorded in response to application of 1M of the indicated ligands (arrows). Line traces are derived from several representative
individual HEK-G15 cells expressing GFP-tagged forms of the indicated receptors. Similar results were obtained with untagged forms of these
receptors (not shown). (I and J) Densensitization kinetics of untagged mrgA1 and mrgA4 in HEK 293 cells. Insets show the decline in peak
responses following repeated application of ligands (arrows). Responses returned to normal within 15–20 min (break in abscissa).
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The structure of such endings also varies according to The Significance of mrg Sequence Diversity
The finding that mrgA1 and A4 can serve as receptorsthe peripheral target, such as dermal layer, type of hair
for neuropeptides begs the question of the reason forfollicle, blood vessels, etc. There are currently no molec-
the diversity of the mrg gene family. One possibility isular correlates of such diversity. The ability to mark mrg-
that this diversity reflects different affinities for unknownexpressing neurons with genetically encoded axonal
mammalian neuropeptides. Thus far, only four RFamidetracers (Mombaerts et al., 1996) should afford a means
pre-propeptide precursors—those encoding NPFF/of relating their expression to such anatomical, as well
NPAF (Perry et al., 1997; Vilim et al., 1999), Prolactin-as physiological, axes of sensory neuron diversity, and
Releasing Peptide (PrRP) (Hinuma et al., 1998), RFRPmay provide further clues to the function of these re-
(Hinuma et al., 2000), and KiSS (Ohtaki et al., 2001)—ceptors.
have been described in mammals. By contrast, the C.
elegans genome contains over 20 genes encoding more
than 50 different RFamide neuropeptides (Nelson et al.,mrgAs Encode Probable Neuropeptide Receptors
1998; Li et al., 1999). Perhaps there are many more suchThe structure of mrgAs suggests that they function as
neuropeptides to be discovered in mammals.receptors. Although a similar conclusion has been
An alternative is that the diversity of mrg receptorsdrawn for other orphan GPCRs expressed in peripheral
might reflect different affinities for a single, or smallsensory neurons (Buck and Axel, 1991; Dulac and Axel,
number of, ligands, rather than different specificities1995; Matsunami and Buck, 1997; Adler et al., 2000;
that discriminate amongst a larger number. For example,Matsunami et al., 2000), it has with a few exceptions
neurons expressing different mrgs might respond to a(Zhao et al., 1998; Chandrashekar et al., 2000) been
common modulator(s) of peripheral nociceptor sensitiv-difficult to demonstrate this directly. Here we have
ity, but with different affinities. Such a mechanism could,shown that mrgA1 and A4 can act as neuropeptide re-
for example, allow graded regulation of a population ofceptors when expressed in heterologous cells. Although
functionally equivalent neurons. It is even conceivablewe do not claim to have identified the authentic ligand(s)
that mrgs function as axon guidance molecules, as hasfor these receptors, the nature of the molecules that
been demonstrated for odorant receptors in olfactoryactivate them may provide some clues as to their selec-
sensory neurons (Wang et al., 1998). In that system, thetivity. Specifically, mrgA1 and A4 were optimally acti-
diversity of odorant receptors is thought to reflect a
vated by RFamide neuropeptides, such as FMRFamide,
graded series of affinities for guidance molecules ex-
FLRFamide, NPFF, and NPAF. In contrast, mrgA1 was
pressed on target cells (Wang et al., 1998). These possi-
not activated by formyl-Met-Leu-Phe, which lacks an
bilities are not mutually exclusive; if the olfactory GPCRs
amidated C-terminal phenylalanine. These data suggest can play a dual role as receptors for small molecule
that mrgA1 and A4 may be receptors for RFamide-family ligands and as determinants of axon targeting, it could
neuropeptides, if not for NPFF and NPAF themselves. be true for other diverse families of GPCRs expressed
However, the fact that ACTH activated mrgA1 and A4 in peripheral sensory neurons as well. Clearly, the identi-
with equal efficacy as NPFF and NPAF, respectively, fication of the mrg family raises far more questions than
raises the possibility that the authentic ligands for these it answers. It should, however, open new avenues for
receptors are peptides unrelated to RFamides. the exploration of nociceptor development and function.
Binding sites for NPAF/NPFF analogs have been de-
tected on primary sensory neuron fibers in the dorsal Experimental Procedures
horn of the spinal cord (Gouarderes et al., 1996; Gouar-
Molecular Cloning of mrgA Familyderes et al., 2000). Furthermore, injection of NPFF ana-
PCR-amplified cDNAs from wild-type and Ngn1/ DRG were usedlogs into the spinal cord produces long-lasting analgesia
as tester and driver, respectively, in the PCR-Select subtractive
in several chronic pain models (reviewed in Panula et hybridization protocol (Clontech). Details of the procedure are avail-
al., 1999). These data are consistent with the idea that able (see Supplemental Data). Additional members of the mouse
MrgA1 and A4 could serve as receptors for these mrg family and human mrgs were identified bioinformatically using
TBLASTN and the Celera mouse and human (Venter et al., 2001)RFamide neuropeptides, and may modulate nocicep-
sequence databases. 26 ORFs identified in this manner were verifiedtion, in vivo. However, two other human candidate
by high-fidelity PCR amplification of mouse genomic DNA or human
GPCRs for NPAF and NPFF unrelated to mrgAs have BAC clones and sequencing. These verified sequences have been
been identified, called hNPFF1 and hNPFF2 (Bonini et deposited in GenBank (see Accession Numbers, below). Additional
al., 2000; Elshourbagy et al., 2000; Hinuma et al., 2000). unverified sequences were used in the construction of the phyloge-
netic tree (Figure 1B) and are available (see Supplemental Data).Rat NPFF2 is activated by NPAF and NPFF in HEK-G15
cells more strongly than are mrgA1 and A4, and unlike
In Situ Hybridization and Immunohistochemistrythe latter receptors is not activated by ACTH (our unpub-
Nonisotopic in situ hybridization on frozen sections was performed
lished data). RT-PCR experiments indicate that rNPFF2 as previously described using cRNA probes (Ma et al., 1996; Perez
is expressed in DRG (Bonini et al., 2000), and we have et al., 1999). Eight mrgAs, five mrgBs, and mrgD were used as
confirmed this in neonatal mouse DRG by in situ hybrid- probes. At least ten DRGs were analyzed to count the number of
neurons positive for each probe. Details of double-labeling proce-ization (M.J.Z., unpublished data). Whether the same
dures are available (see Supplemental Data).neurons coexpress rNPFF2 and MrgAs is not yet clear.
Thus, while some primary sensory neurons clearly ex-
Calcium Imaging
press receptors for NPFF/NPAF (Rebeyrolles et al., HEK 293 cells were obtained from the ATCC. The HEK-G15 cell
1996; Askwith et al., 2000), the gene(s) encoding these line stably expressing G15 was provided by Aurora Biosciences
Corporation. Details of growth and transfection procedures arereceptors in vivo remain to be defined.
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available (see Supplemental Data). Calcium imaging using Fura-2 vine, J.D., and Julius, D. (1997). The capsaicin receptor: a heat-
activated ion channel in the pain pathway. Nature 389, 816–824.AM (Molecular Probes) was carried out using a continuous perfusion
apparatus essentially as described in Tsien et al. (1985) and Chan- Caterina, M.J., Leffler, A., Malmberg, A.B., Martin, W.J., Trafton, J.,
drashekar et al. (2000). Details are available (see Supplemental Petersen-Zeitz, K.R., Koltzenburg, M., Basbaum, A.I., and Julius, D.
Data). (2000). Impaired nociception and pain sensation in mice lacking the
capsaicin receptor. Science 288, 306–313.
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